Metraipolis › archive › dc_18d3bb2dd611
Prognostic model for lung adenocarcinoma based on experimental drug-resistant cell lines and clinical patients — Europe PMC PMID:41358202
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41358202
- DOI
- 10.3389/fmolb.2025.1654426
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T09:16:05.109Z
- SHA-256 of the archived text
2ca31dbf7a2572cd0ff8b2c41f506e9ab4d67eaf7cb2683f7b0d011484f1c83e- Stable URL of this page
https://metraipolis.com/documento/dc_18d3bb2dd611
How to cite
Prognostic model for lung adenocarcinoma based on experimental drug-resistant cell lines and clinical patients — Europe PMC PMID:41358202 — Europe PMC (en), https://europepmc.org/article/MED/41358202 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_18d3bb2dd611 (Metraipolis archive dc_18d3bb2dd611, sha256 2ca31dbf7a2572cd0ff8b2c41f506e9ab4d67eaf7cb2683f7b0d011484f1c83e)
BibTeX
@misc{dc18d3bb2dd611,
title = {Prognostic model for lung adenocarcinoma based on experimental drug-resistant cell lines and clinical patients — Europe PMC PMID:41358202},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41358202},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_18d3bb2dd611; sha256 2ca31dbf7a2572cd0ff8b2c41f506e9ab4d67eaf7cb2683f7b0d011484f1c83e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41358202. Agents can read the archived copy with the MCP tool read_document.